Advair devices progress down the production line at GlaxoSmithKline's manufacturing facility in Zebulon. GSK executives told analysts recently they are bracing for a generic competitor to Advair, whose U.S. patent expires in 2016.
Advair devices progress down the production line at GlaxoSmithKline's manufacturing facility in Zebulon. GSK executives told analysts recently they are bracing for a generic competitor to Advair, whose U.S. patent expires in 2016. Chris Seward cseward@newsobserver.com
Advair devices progress down the production line at GlaxoSmithKline's manufacturing facility in Zebulon. GSK executives told analysts recently they are bracing for a generic competitor to Advair, whose U.S. patent expires in 2016. Chris Seward cseward@newsobserver.com

GSK emerges with smaller, more focused NC presence

June 12, 2015 6:22 PM

More Videos

  • Take a sneak peek inside an Amazon fulfillment center

    The Amazon U.S. fulfillment network consists of more than 50 fulfillment centers, over 20 sortation centers and more than 90,000 full-time employees. Have a look around.